149 related articles for article (PubMed ID: 10881021)
1. Decreased galectin-3 expression in prostate cancer.
Pacis RA; Pilat MJ; Pienta KJ; Wojno K; Raz A; Hogan V; Cooper CR
Prostate; 2000 Jul; 44(2):118-23. PubMed ID: 10881021
[TBL] [Abstract][Full Text] [Related]
2. Alteration of the cytoplasmic/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression.
van den Brûle FA; Waltregny D; Liu FT; Castronovo V
Int J Cancer; 2000 Jul; 89(4):361-7. PubMed ID: 10956411
[TBL] [Abstract][Full Text] [Related]
3. Effects of galectin-3 expression on growth and tumorigenicity of the prostate cancer cell line LNCaP.
Ellerhorst JA; Stephens LC; Nguyen T; Xu XC
Prostate; 2002 Jan; 50(1):64-70. PubMed ID: 11757037
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of endogenous galectin-1 and galectin-3 in human prostate cancer cell lines and effects of overexpressing galectin-1 on cell phenotype.
Ellerhorst J; Nguyen T; Cooper DN; Lotan D; Lotan R
Int J Oncol; 1999 Feb; 14(2):217-24. PubMed ID: 9917495
[TBL] [Abstract][Full Text] [Related]
5. Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues.
Wu GJ; Varma VA; Wu MW; Wang SW; Qu P; Yang H; Petros JA; Lim SD; Amin MB
Prostate; 2001 Sep; 48(4):305-15. PubMed ID: 11536311
[TBL] [Abstract][Full Text] [Related]
6. Galectin-1 and galectin-3 expression in human prostate tissue and prostate cancer.
Ellerhorst J; Troncoso P; Xu XC; Lee J; Lotan R
Urol Res; 1999 Oct; 27(5):362-7. PubMed ID: 10550525
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.
Wu GJ; Wu MW; Wang SW; Liu Z; Qu P; Peng Q; Yang H; Varma VA; Sun QC; Petros JA; Lim SD; Amin MB
Gene; 2001 Nov; 279(1):17-31. PubMed ID: 11722842
[TBL] [Abstract][Full Text] [Related]
8. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
9. 90K/Mac-2 binding protein is expressed in prostate cancer and induces promatrilysin expression.
Bair EL; Nagle RB; Ulmer TA; Laferté S; Bowden GT
Prostate; 2006 Feb; 66(3):283-93. PubMed ID: 16245278
[TBL] [Abstract][Full Text] [Related]
10. A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease.
Laderach DJ; Gentilini LD; Giribaldi L; Delgado VC; Nugnes L; Croci DO; Al Nakouzi N; Sacca P; Casas G; Mazza O; Shipp MA; Vazquez E; Chauchereau A; Kutok JL; Rodig SJ; Elola MT; Compagno D; Rabinovich GA
Cancer Res; 2013 Jan; 73(1):86-96. PubMed ID: 23108139
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures.
Lahm H; André S; Hoeflich A; Fischer JR; Sordat B; Kaltner H; Wolf E; Gabius HJ
J Cancer Res Clin Oncol; 2001; 127(6):375-86. PubMed ID: 11414198
[TBL] [Abstract][Full Text] [Related]
12. Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon.
Schoeppner HL; Raz A; Ho SB; Bresalier RS
Cancer; 1995 Jun; 75(12):2818-26. PubMed ID: 7773932
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of galectin-3 in basal cell carcinoma of the skin.
Castronovo V; Liu FT; van den Brule FA
Int J Oncol; 1999 Jul; 15(1):67-70. PubMed ID: 10375595
[TBL] [Abstract][Full Text] [Related]
14. galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas.
Cindolo L; Benvenuto G; Salvatore P; Pero R; Salvatore G; Mirone V; Prezioso D; Altieri V; Bruni CB; Chiariotti L
Int J Cancer; 1999 Feb; 84(1):39-43. PubMed ID: 9988230
[TBL] [Abstract][Full Text] [Related]
15. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications Part 2. Tumorigenic cell lines.
Webber MM; Bello D; Quader S
Prostate; 1997 Jan; 30(1):58-64. PubMed ID: 9018337
[TBL] [Abstract][Full Text] [Related]
16. Expression of homeobox gene-GBX2 in human prostatic cancer cells.
Gao AC; Isaacs JT
Prostate; 1996 Dec; 29(6):395-8. PubMed ID: 8977637
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of homeobox gene GBX2 expression inhibits human prostate cancer clonogenic ability and tumorigenicity.
Gao AC; Lou W; Isaacs JT
Cancer Res; 1998 Apr; 58(7):1391-4. PubMed ID: 9537237
[TBL] [Abstract][Full Text] [Related]
18. Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells.
Grzmil M; Thelen P; Hemmerlein B; Schweyer S; Voigt S; Mury D; Burfeind P
Am J Pathol; 2003 Aug; 163(2):543-52. PubMed ID: 12875974
[TBL] [Abstract][Full Text] [Related]
19. Involvement of decreased Galectin-3 expression in the pathogenesis and progression of prostate cancer.
Merseburger AS; Kramer MW; Hennenlotter J; Simon P; Knapp J; Hartmann JT; Stenzl A; Serth J; Kuczyk MA
Prostate; 2008 Jan; 68(1):72-7. PubMed ID: 18008332
[TBL] [Abstract][Full Text] [Related]
20. Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer.
Freedland SJ; Seligson DB; Liu AY; Pantuck AJ; Paik SH; Horvath S; Wieder JA; Zisman A; Nguyen D; Tso CL; Palotie AV; Belldegrun AS
Prostate; 2003 Apr; 55(1):71-80. PubMed ID: 12640663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
